Latest Antimalarial drug Stories
BURLINGAME, Calif., May 20 /PRNewswire/ -- GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S.
MEMPHIS, Tenn., May 19 /PRNewswire/ -- An international team led by St.
Amodiaquine was introduced as an antimalarial drug, but was withdrawn when serious adverse effects were observed.
SAN DIEGO, March 29 /PRNewswire/ -- Trius Therapeutics, Inc.
According to a Nature Genetics study, an international group of researchers has used genomics to decode the blueprint of Plasmodium falciparum â€“ a strain of malaria most resistant to drugs that causes the most deaths around the world.
The first results from a large-scale study of key antimalarial medicines in ten Sub-Saharan African countries reveal that a high percentage of medicines circulating on national markets are of substandard quality and thus may contribute to the growth of drug-resistant strains of Plasmodium falciparum, the most virulent form of malaria.
Inadequacies May Contribute to Drug Resistance ROCKVILLE, Md., Feb.
This breakthrough makes NTU's School of Biological Sciences a global leader in transcriptional profiling of malaria -- and better yet, could lead to a cure for malaria.
Walter and Eliza Hall Institute researchers have identified a key protein used by the malaria parasite to transform human red blood cells, ensuring the parasite's survival.
Multinational team of researchers focuses on how parasites use enzymes to survive and spread disease.
- A trick or prank.